Institutional experience on the impact of glucagon-like peptide-1 agonists (GLP-1) on glycemic control and weight loss in patients with type 2 diabetes at the Dubai Diabetes Center, United Arab Emirates
Dima Abdelmannan(Dubai Health Authority), A. Enrique Caballero(Beth Israel Deaconess Medical Center), Heitham K. Ajlouni, Muhammad H. Farooqi(Dubai Pharmacy College), Marwan Zidan, Manal AlBuflasa, Farya Rahman(Zayed Military Hospital)
Cited by 4
Related Papers
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
|Diabetes|1999|649
Restoration of Sensation, Reduced Pain, and Improved Balance in Subjects With Diabetic Peripheral Neuropathy
|Diabetes Care|2004|136
The Effect of Vitamin E on Endothelial Function of Micro- and Macrocirculation and Left Ventricular Function in Type 1 and Type 2 Diabetic Patients
|Diabetes|2005|85
Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020
|Dubai Diabetes and Endocrinology Journal|2020|41